aXichem AB (FRA:A6X) E10: €-0.05 (As of Mar. 2026)


FRA:A6X aXichem AB FRA:A6X
61 GF Score
Price €0.11
GF Value €0.22
View Full Analysis

What is aXichem AB E10?

aXichem AB FRA:A6X -2.70% 61 E10 is €-0.05 as of Mar. 2026. GuruFocus rates FRA:A6X with a GF Score™ of 61/100 and a GF Value™ of €0.22.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

aXichem AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.005. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.05 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 3.00% per year. During the past 5 years, the average E10 Growth Rate was -1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of aXichem AB was 3.00% per year. The lowest was -5.50% per year. And the median was -2.20% per year.

As of today (2026-07-02), aXichem AB's current stock price is €0.108. aXichem AB's E10 for the quarter that ended in Mar. 2026 was €-0.05. aXichem AB's Shiller PE Ratio of today is .


aXichem AB  (FRA:A6X) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


aXichem AB E10 Related Terms


aXichem AB E10 Historical Data

* Premium members only.

The historical data trend for aXichem AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aXichem AB E10 Chart

aXichem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 -0.08 -0.08 -0.05 -0.06

aXichem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.07 -0.07 -0.06 -0.05

FRA:A6X vs LIN, SHW, ECL: E10 Comparison

For the Specialty Chemicals subindustry, aXichem AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aXichem AB Shiller PE Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, aXichem AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where aXichem AB's Shiller PE Ratio falls into.


FRA:A6X
61GF Score
aXichem AB FRA:A6X
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aXichem AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, aXichem AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.005/139.1000*139.1000
=-0.005

Current CPI (Mar. 2026) = 139.1000.

aXichem AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.019 103.800 -0.025
201609 -0.013 104.200 -0.017
201612 -0.016 104.400 -0.021
201703 -0.010 105.000 -0.013
201706 -0.011 105.800 -0.014
201709 -0.012 105.900 -0.016
201712 -0.015 106.100 -0.020
201803 -0.011 107.300 -0.014
201806 -0.018 108.500 -0.023
201809 -0.015 109.500 -0.019
201812 -0.017 109.800 -0.022
201903 -0.014 110.400 -0.018
201906 -0.021 110.600 -0.026
201909 -0.017 111.100 -0.021
201912 -0.020 111.300 -0.025
202003 -0.017 111.200 -0.021
202006 -0.021 112.100 -0.026
202009 -0.018 112.900 -0.022
202012 -0.021 112.900 -0.026
202103 -0.019 114.600 -0.023
202106 -0.023 115.300 -0.028
202109 -0.017 117.500 -0.020
202112 -0.028 118.900 -0.033
202203 -0.020 119.800 -0.023
202206 -0.028 122.600 -0.032
202209 -0.029 125.600 -0.032
202212 -0.018 125.900 -0.020
202303 -0.026 127.600 -0.028
202306 -0.021 130.400 -0.022
202309 -0.018 129.800 -0.019
202312 -0.023 131.900 -0.024
202403 -0.022 132.600 -0.023
202406 -0.003 133.800 -0.003
202409 -0.013 133.700 -0.014
202412 -0.009 134.800 -0.009
202503 -0.009 136.100 -0.009
202506 -0.005 137.800 -0.005
202509 -0.005 138.500 -0.005
202512 -0.008 139.100 -0.008
202603 -0.005 139.100 -0.005

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.05 mean?
aXichem AB (FRA:A6X) has a E10 of €-0.05 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on aXichem AB and its competitors.
Is aXichem AB's E10 too high?
aXichem AB's current E10 is €-0.05. Overall, aXichem AB has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's E10 compare to LIN and SHW?
aXichem AB's E10 of €-0.05 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Chemicals company?
A good E10 depends on the Chemicals industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on aXichem AB and its competitors. aXichem AB's current E10 is €-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current E10 of €-0.05. The stock's GF Value™ is €0.22, compared to a current price of €0.11 — trading 50.9% below its estimated fair value. The current E10 is €-0.05. aXichem AB's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current E10 is €-0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aXichem AB (FRA:A6X) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of €0.11 is trading 50.9% below its estimated GF Value™ of €0.22.

Key valuation signals for FRA:A6X:

  • E10: €-0.05
  • GF Value™: €0.22 vs. price of €0.11 (50.9% below fair value)
  • GF Score™: 61/100

No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aXichem AB Business Description

Other Exchanges AXIC A:Sweden
Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
61GF Score

Get the complete analysis for FRA:A6X

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€0.22
GF Value